Laddar...
Lipidic Nanoparticles Comprising of Phosphatidylinositol Mitigate Immunogenicity and Improve Efficacy of Recombinant Human Acid Alpha-Glucosidase in a Murine Model of Pompe Disease
Enzyme replacement therapy with recombinant human acid α-glucosidase (rhGAA) is complicated by the formation of anti-rhGAA antibodies, a short circulating half-life, instability in the plasma, and limited uptake into target tissue. Previously, we have demonstrated that phosphatidylinositol (PI) cont...
Sparad:
| I publikationen: | J Pharm Sci |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5812781/ https://ncbi.nlm.nih.gov/pubmed/29102549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2017.10.038 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|